Phase 1 Hormone-refractory Prostate Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Gastric CancerColon CancerTriple Negative Breast Cancer(TNBC)+8 more

SHY Therapeutics30 enrolled3 locationsNCT07705334

Recruiting

Phase 1

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Hormone-refractory Prostate Cancer

Vir Biotechnology, Inc.437 enrolled12 locationsNCT05997615